Increasing access to sensitive binding interactions analysis
Pall ForteBio, a leading supplier of instrumentation for accelerated drug discovery and development, has announced the launch of the Octet K2 system, a new entry point into the Octet line of label-free interaction analysis systems.
Now available globally, the Octet K2 system offers high-performance, budget-friendly kinetic characterisation of antibody, protein and small-molecule binding interactions.
Using Pall ForteBio’s bio-layer interferometry (BLI) technology, all Octet systems offer a fluidics-free alternative to surface plasmon resonance with a variety of off-the-shelf 'Dip and Read' biosensors for more rapid assay development and optimisation. The Octet K2 system increases accessibility to BLI as a two-channel instrument, providing exquisite binding affinity data for molecules down to 150 daltons in size.
‘Label-free users in academia and at startup biotech companies have historically been stuck between choosing to pay a premium for capacity they will never use or to settle for a lower-performance ‘starter’ system,’ commented Robert Wicke, General Manager at Pall ForteBio. ‘The Octet K2 system offers scientists the throughput they need to meet their budget without compromising on assay sensitivity.’